Clinical significance of immunohistochemical markers of diffuse large B-cell lymphoma in the rituximad era
(ASH Annual Meeting 2010)
Multicenter phasa ll study of the CyclOBEAP regimen for patients with peripheral T-cell lymphoma with analysis of biomakers
(ASH Annual Meeting 2010)
Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B cell lymphoma after riuximad combination chemotherapy
(ASH Annual Meeting 2010)